- Global Pharma News & Resources

Global Acute Kidney Injury (AKI) Report 2018 - Market Insights, Epidemiology and Market Forecast 2016-2027 -

The "Acute Kidney Injury (AKI) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to's offering.

Acute Kidney Injury (AKI) - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of AKI in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Acute Kidney Injury (AKI) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

The Acute Kidney Injury (AKI) market report gives the thorough understanding of the Acute Kidney Injury by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Acute Kidney Injury in the US, Europe, and Japan.

Key Topics Covered:

1. Key Insights

2. Acute Kidney Injury Market: Overview at a Glance

3. Acute Kidney Injury (AKI): Disease Background and Overview

4. Epidemiology and Patient Population

5. Country Wise-Epidemiology of Acute Kidney Injury

6. Current Treatment Practices

7. Unmet Needs

8. Emerging Therapies

9. Acute Kidney Injury: 7 Major Market Analysis

10. Market Outlook by Country

11. Trends in Cost of Therapies in Acute Kidney Injury

12. Market Drivers

13. Market Barriers

Companies Mentioned

  • Thrasos Therapeutics
  • AM Pharma
  • Quark Pharmaceuticals
  • Angion Biomedica
  • Alloksys
  • LG Life Sciences
  • Exponential Biotherapies

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 29-Oct-2018